Scan-Auto Analyzer for measuring IGT and insulin resistance to detect very early onset of Diabetes, screening & prevention of Cardiometabolic risk
Scan-Auto Analyzer uses patented SudoScan technology to measure Diabetic and Cardiometabolic Risk in a non-invasive, 2-minute test. The technology uses stainless steel electrodes to measure electrochemical sweat conductance (ESC) in a Sweat Gland Stress Test. The resultant conductance values are analyzed in seconds using a proprietary algorithm, which gives an easy-to-understand risk score. Clinical studies show that the test is able to predict Diabetes up to 3 years earlier than HbA1C. The Scan-Auto Analyzer test allows doctors to intervene early, which may slow/ halt the progression of diabetes, and in some cases even reverse it. Scan-Auto Analyzer is used by general practitioners, Endocrinologists, pharmacists, cardiologists, and neurologists. Recent clinical studies have shown Scan-Auto Analyzer to be highly accurate and reproducible in head-to-head comparisons with conventional blood tests. ESC values measured by SCAN had a sensitivity of 75% and a specificity of 100%. Its good sensitivity, specificity, and reproducibility make Scan-Auto Analyzer a reliable tool to assess sudomotor dysfunction, a clinical manifestation of autonomic neuropathy in patients with cardiometabolic risk.